Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer Susceptibility

This publication has 29 references indexed in Scilit:

• A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
  American Journal of Human Genetics, 2002
• Chk2 Activation and Phosphorylation-Dependent Oligomerization
  Molecular and Cellular Biology, 2002
• Structural and Functional Versatility of the FHA Domain in DNA-Damage Signaling by the Tumor Suppressor Kinase Chk2
  Molecular Cell, 2002
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
  Nature Genetics, 2002
• Concomitant inactivation of p53 and Chk2 in breast cancer
  Oncogene, 2002
• A robust method for detectingCHK2/RAD53 mutations in genomic DNA
  Human Mutation, 2002
• Chk2 kinase — a busy messenger
  Nature Reviews Molecular Cell Biology, 2001
• Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome
  Journal of Medical Genetics, 2001
• The North Cumbria Community Genetics Project.
  Journal of Medical Genetics, 1998
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
  Nature Genetics, 1997